Newsflash #4
Dear TELSTAR-2 collaborators, Please ensure that the eCRF is filled out fully and correctly. We would like to ask your attention for the following: Current status
Dear TELSTAR-2 collaborators, Please ensure that the eCRF is filled out fully and correctly. We would like to ask your attention for the following: Current status
Dear TELSTAR-2 collaborators, Please ensure that the trial is discussed with a patient’s legal representatives after randomization. If the family declines participation, explicitly ask whether the use of already collected …
Dear colleagues, First of all, best (belated) wishes for 2026! We look back on a year where the TELSTAR-2 trial had a great start. As you can see below on …
Substantial Modification-2 (SM-2) got approved by the ethical committee in the Netherlands and in Belgium. Implications SM-2:
Dear colleagues, First of all, thank you for your continued efforts and dedication to the TELSTAR-2 trial! Your commitment is vital to the success of the trial and highly appreciated! …
Substantial Modification-1 (SM-1) got approved by the ethical committee in the Netherlands and in Belgium. Implications SM-1:
TELSTAR-2 officially kicked off today! The Rijnstate Hospital has included the first patient.
